| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |